Skip to main content
Log in

Anal squamous cell carcinoma: a retrospective case series

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

Anal cancer is a relatively rare cancer with 660 cases diagnosed in 2000–2015 in Ireland (1). The current standard treatment is radical chemoradiotherapy (CRT). The aim of our study was to review the treatment and outcomes of patients with localised anal squamous cell carcinoma (SCC), who received radical treatment in our radiation oncology network between 2008 and 2014 inclusive.

Methods

Data were collected retrospectively from ARIA® oncology information system and patient charts. Statistical analyses were performed using IBM® SPSS® statistical software version 25.0.

Results

Seventy-nine cases of anal SCC were identified. Mean age of patients at commencement of radiotherapy (RT) was 60.2 years (standard deviation: 13.1 years). The most common total RT dose was 50.4 Gy in 28 fractions (N = 58; 73.4%). Median follow-up was 5.6 years. Two (2.6%) patients had persistent disease, seventeen (21.8%) patients developed loco-regional recurrence and nine (11.5%) patients developed solid organ metastases, four of whom had complete treatment response at the primary site. Eight patients underwent salvage anal surgery following completion of RT. Median overall survival was 10.5 years (95% confidence interval (CI) 5.1–15.8 years), median loco-regional relapse-free survival was 10.4 years (95% CI 4.4–16.3 years) and median disease-free survival was 9.3 years (95% CI 6.3–12.2 years).

Conclusion

Our study demonstrates that treatment for anal SCC and outcomes following definitive CRT in Ireland during the study period were comparable to international standards.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Availability of data and material

Data are available from the corresponding author.

References

  1. National Cancer Registry Ireland (2015) Incidence statistics [online]. Available from: https://www.ncri.ie/data/incidence-statistics [accessed 24 January 2021]

  2. Klas JV, Rothenberger DA, Wong WD, Madoff RD (1999) Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 85(8):1686–1693

    Article  CAS  Google Scholar 

  3. SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) [database on the Internet]. Bethesda, MD: National Cancer Institute. Available from https://seer.cancer.gov/csr/1975_2009_pops09/

  4. Nigro ND, Vaitkevicius VK, Considine B (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17(3):354–356

    Article  CAS  Google Scholar 

  5. Nigro ND, Vaitkevicius VK, Buroker T, Bradley GT et al (1981) Combined therapy for cancer of the anal canal. Dis Colon Rectum 24(2):73–75

    Article  CAS  Google Scholar 

  6. Nigro ND, Seydel HG, Considine B et al (1983) Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 51(10):1826–1829

    Article  CAS  Google Scholar 

  7. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348(9034):1049–54

  8. Bartelink H, Roelofsen F, Eschwege F et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15(5):2040–2049

    Article  CAS  Google Scholar 

  9. Shridhar R, Shibata D, Chan E, Thomas CR (2015) Anal cancer: current standards in care and recent changes in practice. CA Cancer J Clin 65(2):139–62

  10. Flam M, John M, Pajak TF et al (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14(9):2527–2539

    Article  CAS  Google Scholar 

  11. James RD, Glynne-Jones R, Meadows HM et al (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol 14(6):516–524

    Article  CAS  Google Scholar 

  12. Wilkinson JR, Morris EJ, Downing A et al (2014) The rising incidence of anal cancer in England 1990–2010: a population-based study. Colorectal Dis 16(7):O234–O239

    Article  CAS  Google Scholar 

  13. Nelson RA, Levine AM, Bernstein L et al (2013) Changing patterns of anal canal carcinoma in the United States. J Clin Oncol 31(12):1569–1575

    Article  Google Scholar 

  14. AJCC: Anus (2010) In: Edge SB, Byrd DR, Compton CC, et al., (eds.) AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer pp 165–73

  15. Kachnic LA, Tsai HK, Coen JJ et al (2012) Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiat Oncol Biol Phys 82(1):153–158

    Article  Google Scholar 

  16. Kachnic LA, Winter K, Myerson RJ et al (2013) RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 86(1):27–33

    Article  CAS  Google Scholar 

  17. Glynne-Jones R, Nilsson PJ, Aschele C et al (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol 111(3):330–339

    Article  Google Scholar 

  18. Chuong MD, Freilich JM, Hoffe SE et al (2013) Intensity-modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal. Gastrointest Cancer Res 6(2):39–45

  19. Saarilahti K, Arponen P, Vaalavirta L, Tenhunen M (2008) The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer. Radiother Oncol 87(3):383–390

    Article  Google Scholar 

  20. Eng C, Messick C, Glynne-Jones R (2019) The management and prevention of anal squamous cell carcinoma. Am Soc Clin Oncol Educ Book 39:216–225

    Article  Google Scholar 

  21. Pessia B, Romano L, Giuliani A et al (2020) Squamous cell anal cancer: management and therapeutic options. Ann Med Surg (Lond) 55:36–46

    Article  Google Scholar 

  22. Sebag-Montefiore D, Adams R, Bell S (2016) The development of an umbrella trial (PLATO) to address radiation therapy dose questions in the locoregional management of squamous cell carcinoma of the anus. Int J Radiat Oncol 96:E164–E165

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Orla Anne Houlihan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Houlihan, O.A., Monaghan, O., O’Sullivan, S. et al. Anal squamous cell carcinoma: a retrospective case series. Ir J Med Sci 191, 681–686 (2022). https://doi.org/10.1007/s11845-021-02643-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-021-02643-x

Keyword

Navigation